Regorafenib is a cancer medication that interferes with the growth and spread of cancer cells in the body. Regorafenib is used to treat colorectal cancer. It is also used to treat a rare type of tumor that can affect the esophagus, stomach, or intestines. Regorafenib is usually given after other cancer medications have been tried without success. Regorafenib may also be used for purposes not listed in this medication guide.
Stivarga is the brand name form of regorafenib, a type of oral cancer medication. Stivarga works by interfering with the growth and spread of cancer cells in the body. Stivarga is usually given after other cancer drugs have failed. Stivarga was developed by a German company Bayer and has been approved for use in type-targeted therapy. Stivarga works by inhibiting growth in various types of kinase proteins which inhibit growth of cancerous tumors.